MedinCell S.A.
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceuti…
Biotechnology
FR, Jacou [HQ]
Cash Flow Statements
9 Records · Starting from 2015In Million EUR. Margins, Growth Rates In %
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Cash Flow (OCF) | - - | -3.00 | -5.00 | -15.00 | -13.00 | -15.00 | -22.00 | -25.00 | -11.00 | |
| Operating Cash (Net) | - - | -3.00 | -5.00 | -15.00 | -13.00 | -15.00 | -22.00 | -25.00 | -11.00 | |
| Accounts Receivable | -1.00 | 1.00 | - - | - - | - - | -1.00 | -1.00 | -5.00 | 4.00 | |
| Accounts Payable | - - | - - | - - | - - | 1.00 | - - | - - | 1.00 | -2.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | -1.00 | - - | -1.00 | 3.00 | - - | -2.00 | -3.00 | 3.00 | |
| Other WC | - - | -2.00 | - - | -1.00 | 3.00 | 2.00 | -1.00 | 1.00 | - - | |
| Investing Activities | ||||||||||
| Used Cash (Net) | -1.00 | -7.00 | 2.00 | - - | - - | -1.00 | - - | 1.00 | - - | |
| Capital Expenditure | -1.00 | -1.00 | -1.00 | - - | - - | - - | -1.00 | -1.00 | -1.00 | |
| Purchases of Investments | - - | -6.00 | - - | - - | - - | - - | -1.00 | - - | - - | |
| Sale/Maturity of Investment | - - | 6.00 | 3.00 | - - | - - | - - | 1.00 | 2.00 | - - | |
| Property, Plant, Equipment (P&PE) | -1.00 | -1.00 | -1.00 | - - | - - | - - | -1.00 | -1.00 | -1.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | - - | - - | - - | 1.00 | - - | - - | |
| Financing Activities | ||||||||||
| Used Cash (Net) | - - | -14.00 | -8.00 | -29.00 | -5.00 | -51.00 | - - | -6.00 | -25.00 | |
| Debt Repayment | - - | -3.00 | -2.00 | -2.00 | -5.00 | -9.00 | -1.00 | -5.00 | -5.00 | |
| Dividends Paid | - - | -17.00 | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | 22 | - - | - - | - - | - - | 23 | |
| Issued | - - | - - | - - | 22.00 | - - | 42.00 | - - | - - | 23.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | 35.00 | 10.00 | 29.00 | 14.00 | 18.00 | 1.00 | 11.00 | - - | |
| Cash Balances | ||||||||||
| Begin of Period | 1.00 | - - | 3.00 | 8.00 | 21.00 | 8.00 | 44.00 | 19.00 | 6.00 | |
| End of Period | - - | 3.00 | 8.00 | 21.00 | 8.00 | 44.00 | 19.00 | 6.00 | 19.00 | |
| Change | - - | 3.00 | 4.00 | 12.00 | -12.00 | 35.00 | -24.00 | -13.00 | 12.00 | |
| Non-Cash Balances | ||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Stock Based Compensation | - - | - - | - - | - - | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | |
| Other | - - | 1.00 | 1.00 | 4.00 | - - | 5.00 | 7.00 | 15.00 | 4.00 | |
| Highlighted metrics | ||||||||||
| Free Cash Flow (FCF) | -1.00 | -5.00 | -6.00 | -16.00 | -14.00 | -16.00 | -24.00 | -26.00 | -13.00 | |
| Cash Conversion Cycle (CCC) | -1,582.00 | -360.00 | -1,678.00 | 732.00 | -619.00 | -538.00 | 764.00 | 857.00 | 24,689.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | -2.00 | - - | - - |